Tafamidis Meglumine + Rosuvastatin Interaction
Unknowninteraction on record
Description
Coadministration of tafamidis and drugs that are BCRP substrates may increase the exposure of substrates of this transporter (e.g., methotrexate, rosuvastatin, imatinib) and the risk of the substrate-related toxicities.
Source: FDA drug label - tafamidis meglumine